These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 3931138)
1. Efficacy of oral physostigmine in primary degenerative dementia. A double-blind study of response to different dose level. Beller SA; Overall JE; Swann AC Psychopharmacology (Berl); 1985; 87(2):147-51. PubMed ID: 3931138 [TBL] [Abstract][Full Text] [Related]
2. Oral physostigmine treatment for patients with presenile and senile dementia of the Alzheimer's type: a double-blind placebo-controlled trial. Jenike MA; Albert MS; Heller H; Gunther J; Goff D J Clin Psychiatry; 1990 Jan; 51(1):3-7. PubMed ID: 2403997 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine. Davis KL; Mohs RC Am J Psychiatry; 1982 Nov; 139(11):1421-4. PubMed ID: 6753611 [TBL] [Abstract][Full Text] [Related]
4. Physostigmine effects in Alzheimer's disease: relationship to dementia severity. Schwartz AS; Kohlstaedt EV Life Sci; 1986 Mar; 38(11):1021-8. PubMed ID: 3512944 [TBL] [Abstract][Full Text] [Related]
5. Improved verbal learning after outpatient oral physostigmine therapy in patients with dementia of the Alzheimer type. Sevush S; Guterman A; Villalon AV J Clin Psychiatry; 1991 Jul; 52(7):300-3. PubMed ID: 2071560 [TBL] [Abstract][Full Text] [Related]
6. Oral physostigmine and lecithin improve memory in Alzheimer disease. Thal LJ; Fuld PA; Masur DM; Sharpless NS Ann Neurol; 1983 May; 13(5):491-6. PubMed ID: 6347034 [TBL] [Abstract][Full Text] [Related]
8. Long-term administration of oral physostigmine in Alzheimer's disease. Stern Y; Sano M; Mayeux R Neurology; 1988 Dec; 38(12):1837-41. PubMed ID: 3057398 [TBL] [Abstract][Full Text] [Related]
9. No effect from double-blind trial of physostigmine and lecithin in Alzheimer disease. Wettstein A Ann Neurol; 1983 Feb; 13(2):210-2. PubMed ID: 6830183 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of oral physostigmine in the treatment of Alzheimer disease. Sano M; Bell K; Marder K; Stricks L; Stern Y; Mayeux R Clin Neuropharmacol; 1993 Feb; 16(1):61-9. PubMed ID: 8422658 [TBL] [Abstract][Full Text] [Related]
11. Double-blind, randomized, placebo-controlled clinical trial on the efficacy and tolerability of a physostigmine patch in patients with senile dementia of the Alzheimer type. Möller H-J ; Hampel H; Hegerl U; Schmitt W; Walter K Pharmacopsychiatry; 1999 May; 32(3):99-106. PubMed ID: 10463377 [TBL] [Abstract][Full Text] [Related]
12. Effects of oral physostigmine in Alzheimer's disease. Stern Y; Sano M; Mayeux R Ann Neurol; 1987 Sep; 22(3):306-10. PubMed ID: 3674795 [TBL] [Abstract][Full Text] [Related]
13. Effects of physostigmine and lecithin on memory in Alzheimer disease. Peters BH; Levin HS Ann Neurol; 1979 Sep; 6(3):219-21. PubMed ID: 534419 [TBL] [Abstract][Full Text] [Related]